+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ischemia Reperfusion Injury Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5327637
  • Report
  • August 2020
  • Region: Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Angion Biomedica Corp.
  • Curatis Pharma GmbH
  • Nyken B.V.
  • Orexo AB
  • PledPharma AB
  • Proteo, Inc.
  • MORE
Ischemia reperfusion injury (IRI), also known as reoxygenation injury, is tissue damage that arises when blood supply returns to the tissue (reperfusion) after a period of lack of oxygen (ischemia). The symptoms of ischemia injury include bradycardia, headache, hypertension, and seizures.

Market Dynamics

The increase in the number of tissue damage cases and the growing awareness about treatment of reperfusion injury are major factors boosting growth of the global ischemia reperfusion therapeutics market. Moreover, introduction of novel drugs for treatment of complications related to ischemia reperfusion, and the rising research & development activities are propelling the market growth. For instance, in November 2019, Faraday Pharmaceuticals announced positive top-line results from the phase II trial of FDY-5301 for ischemia reperfusion injury therapeutics treatment.

Moreover, factors such as the rising incidence of ischemic reperfusion injury across the globe, and strategic acquisitions of key players for developing novel treatment are expected to favor growth of the market during the period of forecast.

Key features of the study:
  • This report provides in-depth analysis of the global ischemia reperfusion injury therapeutics market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • The study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global ischemia reperfusion injury therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study are Omeros Corporation, Nyken B.V., Opsona Therapeutics Limited, Pharming Group N.V., Orexo AB, PledPharma AB, Proteo, Inc., Prolong Pharmaceuticals, Prothix BV, Zealand Pharma A/S, Stealth BioTherapeutics Inc., Amyndas Pharmaceuticals LLC, Antipodean Pharmaceuticals, Inc., Angion Biomedica Corp., Bayer AG, Bolder Biotechnology, Inc., Biomedica Management Corporation, Curatis Pharma GmbH, Erimos Pharmaceuticals, LLC, Ensemble Therapeutics Corporation, and Gilead Sciences, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global ischemia reperfusion injury therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the global ischemia reperfusion therapeutics market, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:

Global Ischemia Reperfusion Injury Therapeutics Market, By Indication:
  • Heart Injury
  • Kidney Injury
  • Intestine Injury
  • Other Injury
Global Ischemia Reperfusion Injury Therapeutics Market, By Distribution Channel:
  • Retail Pharmacies
  • Hospital Pharmacies
  • Others
Global Ischemia Reperfusion Injury Therapeutics Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
Company Profiles
  • Omeros Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Nyken B.V.
  • Opsona Therapeutics Limited
  • Pharming Group N.V.
  • Orexo AB
  • PledPharma AB
  • Proteo, Inc.
  • Prolong Pharmaceuticals
  • Prothix BV
  • Zealand Pharma A/S
  • Stealth BioTherapeutics Inc.
  • Amyndas Pharmaceuticals LLC
  • Antipodean Pharmaceuticals, Inc.
  • Angion Biomedica Corp.
  • Bayer AG
  • Bolder Biotechnology, Inc.
  • Biomedica Management Corporation
  • Curatis Pharma GmbH
  • Erimos Pharmaceuticals, LLC
  • Ensemble Therapeutics Corporation
  • Gilead Sciences, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Angion Biomedica Corp.
  • Curatis Pharma GmbH
  • Nyken B.V.
  • Orexo AB
  • PledPharma AB
  • Proteo, Inc.
  • MORE
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Indication
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Key Developments
  • Acquisition, Collaborations & Partnerships
  • Epidemiology
4. Global Ischemia Reperfusion Injury Therapeutics Market, Impact of Coronavirus (COVID-19) Pandemic
  • During-COVID situation
  • Post-COVID demand
5. Global Ischemia Reperfusion Injury Therapeutics Market, By Indication, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Heart Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Kidney Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Intestine Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Other Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
6. Global Ischemia Reperfusion Injury Therapeutics Market, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
7. Global Ischemia Reperfusion Injury Therapeutics Market, By Region, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027(%)
  • Y-o-Y Growth Analysis, By Region, 2017 -2027
  • Regional Trends
  • North America
  • Market Size and Forecast, By Types, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.S.
  • Canada
  • Europe
  • Market Size and Forecast, By Types, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Types, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Market Size and Forecast, By Types, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
  • Market Size and Forecast, By Types, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
  • Middle East
  • Market Size and Forecast, By Types, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
8. Competitive Landscape
  • Company Profiles
  • Nyken B.V.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Omeros Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Opsona Therapeutics Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Orexo AB
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Pharming Group N.V.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • PledPharma AB
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Prolong Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Proteo, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Prothix BV
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Stealth BioTherapeutics Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Zealand Pharma A/S
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Amyndas Pharmaceuticals LLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Angion Biomedica Corp.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Antipodean Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Bayer AG
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Biomedica Management Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Bolder Biotechnology, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Curatis Pharma GmbH
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Ensemble Therapeutics Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Erimos Pharmaceuticals, LLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Gilead Sciences, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
9. Section
  • References
  • Research Methodology
  • About Us and Sales Contact
Note: Product cover images may vary from those shown
  • Omeros Corporation
  • Nyken B.V.
  • Opsona Therapeutics Limited
  • Pharming Group N.V.
  • Orexo AB
  • PledPharma AB
  • Proteo, Inc.
  • Prolong Pharmaceuticals
  • Prothix BV
  • Zealand Pharma A/S
  • Stealth BioTherapeutics Inc.
  • Amyndas Pharmaceuticals LLC
  • Antipodean Pharmaceuticals, Inc.
  • Angion Biomedica Corp.
  • Bayer AG
  • Bolder Biotechnology, Inc.
  • Biomedica Management Corporation
  • Curatis Pharma GmbH
  • Erimos Pharmaceuticals, LLC
  • Ensemble Therapeutics Corporation
  • Gilead Sciences, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll